» Articles » PMID: 8824651

Effects of Psyllium Therapy on Stool Characteristics, Colon Transit and Anorectal Function in Chronic Idiopathic Constipation

Overview
Date 1995 Dec 1
PMID 8824651
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Psyllium is widely used in the symptomatic therapy of constipation. Its effects on colonic function and their correlation with symptomatic response have not been defined.

Methods: After a 4-week baseline, placebo, run-in phase, 22 subjects with idiopathic constipation confirmed by prospectively administered stool diaries were randomly assigned to receive either psyllium (5 g b.d., 11 patients) or placebo (11 patients) for 8 weeks, followed by another 4-week wash-out, placebo phase. A colon transit study and anorectal manometry were performed at the beginning and at the end of each study phase. Subjects recorded, in diaries, their daily stool frequency, difficulty with defecation and weekly stool weight.

Results: Stool frequency increased significantly after 8 weeks of psyllium treatment (3.8 +/- 0.4 vs. 2.9 +/- 0.1 stools/week, P < 0.05) as did stool weight (665.3 +/- 95.8 g vs. 405.2 +/- 75.9 g, P < 0.05). Subjects also reported an improvement in stool consistency (stool consistency score: 3.2 +/- 0.2 vs. 3.8 +/- 0.2, P < 0.05) and pain on defecation (pain score: 2.0 +/- 0.4 vs. 2.6 +/- 0.5, P < 0.05) on psyllium. Colon transit and anorectal manometry parameters were unchanged on psyllium. Subjects treated with placebo did not show any change in either subjective or objective measures of constipation.

Conclusions: Psyllium increases stool frequency and weight and improves stool consistency in idiopathic constipation. These effects are not associated with significant changes in either colonic or rectal motor function. We suggest that the beneficial effects of psyllium in constipation are primarily related to a facilitation of the defecatory process.

Citing Articles

Efficacy and Satisfaction of a Chemically Characterized L. Extract-Based Food Supplement for Functional Constipation in Healthy Consumers: Preliminary Results of a Questionnaire-Based Survey.

De Lellis L, Ullah H, Morone M, Buccato D, Baldi A, Di Minno A Nutrients. 2025; 17(1.

PMID: 39796510 PMC: 11723275. DOI: 10.3390/nu17010077.


American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.

Chang L, Chey W, Imdad A, Almario C, Bharucha A, Diem S Gastroenterology. 2023; 164(7):1086-1106.

PMID: 37211380 PMC: 10542656. DOI: 10.1053/j.gastro.2023.03.214.


Dietary fiber and probiotics based on gut microbiota targeting for functional constipation in children with cerebral palsy.

Huang C, Lyu J, Chu C, Ge L, Peng Y, Yang Z Front Pediatr. 2022; 10:1001789.

PMID: 36313885 PMC: 9616111. DOI: 10.3389/fped.2022.1001789.


Kiwifruit and Kiwifruit Extracts for Treatment of Constipation: A Systematic Review and Meta-Analysis.

Eltorki M, Leong R, Ratcliffe E Can J Gastroenterol Hepatol. 2022; 2022:7596920.

PMID: 36247043 PMC: 9560827. DOI: 10.1155/2022/7596920.


The Effect of Fiber Supplementation on Chronic Constipation in Adults: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Van Der Schoot A, Drysdale C, Whelan K, Dimidi E Am J Clin Nutr. 2022; 116(4):953-969.

PMID: 35816465 PMC: 9535527. DOI: 10.1093/ajcn/nqac184.